| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | GF HEALTHCARE (08143): FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 22.09. | GF HEALTHCARE (08143): COMPANY INFORMATION SHEET | - | HKEx | ||
| 22.09. | GF HEALTHCARE (08143): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.09. | GF HEALTHCARE (08143): CAPITAL REORGANISATION BECOMING EFFECTIVE AND ARRANGEMENT ON ODD LOT TRADING AND ADJUSTMENTS TO THE SHARE OPTION SCHEME | - | HKEx | ||
| 14.09. | GF HEALTHCARE (08143): REVISED TIMETABLE IN RELATION TO PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION ... | - | HKEx | ||
| 09.09. | GF HEALTHCARE (08143): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 9 SEPTEMBER 2026 | - | HKEx | ||
| 04.09. | GF HEALTHCARE (08143): FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| GOOD FELLOW HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 07.08. | GF HEALTHCARE (08143): DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): FORM OF PROXY FOR ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED ... | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025/2026 | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): ANNUAL REPORT 2025/2026 | 2 | HKEx | ||
| 14.07. | GF HEALTHCARE (08143): UPDATE ON PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION OF UNISSUED SHARES | - | HKEx | ||
| 08.07. | GF HEALTHCARE (08143): CLARIFICATION ANNOUNCEMENT MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 30.06. | GF HEALTHCARE (08143): MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 26.06. | GF HEALTHCARE (08143): REVISED TIMETABLE IN RELATION TO PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION ... | 1 | HKEx | ||
| 22.06. | GF HEALTHCARE (08143): UPDATE ON PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION OF UNISSUED SHARES | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,470 | +2,14 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,000 | +1,44 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| GERRESHEIMER | 31,900 | -1,24 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,760 | +0,12 % | [Kissigs Nebenwerte-Analyse] Carl Zeiss Meditec: Lässt der Augenspezialist das Tal der Tränen endlich hinter sich? | Im Magazin "Der Nebenwerte Investor" von Traderfox finden sich regelmäßig Analysen von mir zu deutschen Nebenwerten. Das Magazin ist kostenpflichtig und wer dieses oder eine der weiteren Börsenzeitschriften... ► Artikel lesen | |
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness |